RESEARCH ALERT-Cardiome Pharma: Canaccord Genuity raises price target

Wed Nov 20, 2013 1:57am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Nov 20 (Reuters) - Cardiome Pharma Corp : * Cardiome Pharma Corp : Canaccord Genuity raises price target to

$5.50 from $4.50; rating hold For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/CA